Finance

Beta
Ask
Lists
074610:KRX
ENPlus Co Ltd
-100.00%
(-5,110.00) 1D
Jun 16, 2:10:49 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 074610...
Mkt. cap
37.49B
Volume
0.00
52-wk high
₩551
52-wk low
₩511
EPS
-₩2,011
Shares outstanding
8.77M
No. of employees
76
Mkt. cap
37.49B
Volume
0.00
52-wk high
₩551
52-wk low
₩511
EPS
-₩2,011
Shares outstanding
8.77M
No. of employees
76
News stories
From sources across the web
About ENPlus Co Ltd
CEOAhn Young-woong
Employees76
Founded1966
Headquarters-
SectorMachine industry
Websiteen3.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.59B
7.72B
13.10B
6.30B
Cost of goods sold
2.11B
5.52B
9.59B
4.38B
Cost of revenue
2.11B
5.52B
9.59B
4.38B
Research and development expenses
46.43M
23.73M
340.04M
21.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.52B
2.22B
1.83B
2.42B
Operating expense
746.30M
2.39B
2.67B
2.56B
Total operating expenses
2.86B
7.91B
12.26B
6.94B
Operating income
733.20M
-188.51M
841.81M
-638.17M
Other non operating income
1.90B
255.69M
-153.13M
23.25M
EBT including unusual items
-4.26B
-680.17M
-2.30B
-608.73M
EBT excluding unusual items
-139.14M
-130.95M
-107.98M
-906.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
32.51M
107.21M
20.78M
28.68M
Net income
-5.00B
-31.34M
-9.18B
-608.18M
Net profit margin
-139.20%
-0.41%
-70.06%
-9.65%
Earnings per share
-
-
-
-
Interest and investment income
17.16M
15.53M
97.73M
27.81M
Interest expense
-2.75B
-317.16M
-825.44M
-361.32M
Net interest expenses
-2.73B
-301.63M
-727.70M
-333.51M
Depreciation and amortization charges
66.94M
38.38M
304.24M
85.74M
EBITDA
773.04M
-5.36M
1.54B
-436.94M
Gain or loss from assets sale
16.43B
255.78M
542.82M
-298.20M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer